Stavudine (d4T) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. It is known that stavudine is metabolized in cells to the mono-, di- and triphosphate nucleotides but the enzymes responsible for its phosphorylation are as yet unidentified. in particular, there are conflicting results concerning the role of thymidine kinase 1 (TK1) in stavudine metabolism. To gain new insights into this phenomenon we analysed the antiviral activity of stavudine in a TK1-deficient, resistant cell line. The results indicate that TK1 is responsible for the phosphorylation of stavudine but it is not the only enzyme involved in its activation. The other enzyme(s) that might be involved in the metabolism of stavudine, however, are not able to phosphorylate stavudine with the same efficiency as TK1. Since it has been shown that prolonged treatment with zidovudine may induce an in vivo defect in TK1 activity. it is tempting to speculate that patients treated for a long time with zidovudine could be resistant to further treatment with stavudine.

Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line / Turriziani, Ombretta; Simeoni, E; Dianzani, F; Antonelli, Guido. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 3:(1998), pp. -191.

Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line.

TURRIZIANI, Ombretta;ANTONELLI, Guido
1998

Abstract

Stavudine (d4T) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. It is known that stavudine is metabolized in cells to the mono-, di- and triphosphate nucleotides but the enzymes responsible for its phosphorylation are as yet unidentified. in particular, there are conflicting results concerning the role of thymidine kinase 1 (TK1) in stavudine metabolism. To gain new insights into this phenomenon we analysed the antiviral activity of stavudine in a TK1-deficient, resistant cell line. The results indicate that TK1 is responsible for the phosphorylation of stavudine but it is not the only enzyme involved in its activation. The other enzyme(s) that might be involved in the metabolism of stavudine, however, are not able to phosphorylate stavudine with the same efficiency as TK1. Since it has been shown that prolonged treatment with zidovudine may induce an in vivo defect in TK1 activity. it is tempting to speculate that patients treated for a long time with zidovudine could be resistant to further treatment with stavudine.
1998
01 Pubblicazione su rivista::01a Articolo in rivista
Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line / Turriziani, Ombretta; Simeoni, E; Dianzani, F; Antonelli, Guido. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 3:(1998), pp. -191.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/436417
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact